Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDCitius Oncology Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2025 | 1 | -$0.07 | -$0.07 | -$0.07 |
| Q3 2025 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2025 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 0 | $0.00 | $0.00 | $0.00 |
| Q1 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q2 2027 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 0 | $0.00 | $0.00 | $0.00 |
Citius Oncology Inc. Earnings Date And Information
Citius Oncology Inc. last posted its earnings results on Friday, February 14th, 2025. The company reported $-0.09 earnings per share for the quarter, missing analysts' consensus estimates of $-0.06 by $0.03. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Citius Oncology Inc. has generated $0 earnings per share over the last year ($-0.3 diluted earnings per share) and currently has a price-to-earnings ratio of -7.95. Citius Oncology Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based on prior year's report dates.
Citius Oncology Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q1 2025 | N/A | -$0.09 | N/A | $0 | $0 |
| 09/30/2024 | Q4 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 06/30/2024 | Q3 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 03/31/2024 | Q2 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 12/31/2023 | Q1 2024 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2023 | Q4 2023 | N/A | $0.00 | N/A | N/A | $0 |
| 06/30/2023 | Q3 2023 | N/A | $0.00 | N/A | N/A | $0 |
| 03/31/2023 | Q2 2023 | N/A | $0.00 | N/A | N/A | $0 |
| 12/31/2022 | Q1 2023 | N/A | $0.00 | N/A | N/A | $0 |
| 09/30/2022 | Q4 2022 | N/A | $0.00 | N/A | N/A | $0 |
| 06/30/2022 | Q3 2022 | N/A | $0.00 | N/A | N/A | $0 |
| 04/29/2021 | Q2 2021 | N/A | -$0.00 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Citius Oncology Inc. Earnings: FAQ's
Citius Oncology Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 26th, 2025 based offlast year's report dates.
The conference call for Citius Oncology Inc.'s latest earnings report can be listened to online.
The conference call transcript for Citius Oncology Inc.'s latest earnings report can be read online.
Citius Oncology Inc. (:CTOR) has a recorded net income of $-21,148,747.Citius Oncology Inc. has generated $-0.3 earnings per share over the last four quarters.
Citius Oncology Inc. (:CTOR) has a price-to-earnings ratio of -7.95 and price/earnings-to-growth ratio is -0.08.